Close Menu
Home » TwinsUK and BGI to Study Epigenetics of 5,000 Twins under $30M Project

TwinsUK and BGI to Study Epigenetics of 5,000 Twins under $30M Project

Sep 07, 2010
Premium

TwinsUK and Chinese genome institute BGI have launched a $30 million project called Epitwin to study epigenetic differences in 5,000 twins, the organizations said this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

More Troubling Resistance

The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.

Many Dollar Bills There

According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.

'Transparency' Rule Proposed

New rules seek to limit the type of scientific and medical research that can be used to guide public health regulations, the New York Times reports.

Nature Papers Present Method for Simulating Hi-C Data, More

In Nature this week: FreeHi-C approach simulates Hi-C data from interacting genome fragments, and more.

Dec
04
Featured Webinar

Integrating Genetic Data in Clinical Workflows: How CCPM Established a Personalized Health Framework

Sponsored by
BC Platforms

This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).

What's Popular?

In Clinical Sequencing

  1. AMP Attendees Reflect on Uptake of Tumor Mutational Burden Amid Validation, Utility Questions

    Premium

  2. Natera Outlines Plans for Cancer, Transplant Assays; Provides Update on Legal Proceedings

    Premium

  3. Illumina Unveils Liquid Biopsy Version of TSO 500 Panel, Highlights Early User Validations

    Premium

  4. Personalis Q3 Revenues Up 47 Percent

  5. Fulgent Genetics Prices $26.2M Public Stock Offering

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.